1. Home
  2. LIVN vs KYMR Comparison

LIVN vs KYMR Comparison

Compare LIVN & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIVN
  • KYMR
  • Stock Information
  • Founded
  • LIVN 1987
  • KYMR 2015
  • Country
  • LIVN United Kingdom
  • KYMR United States
  • Employees
  • LIVN N/A
  • KYMR N/A
  • Industry
  • LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • LIVN Health Care
  • KYMR Health Care
  • Exchange
  • LIVN Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • LIVN 2.1B
  • KYMR 1.8B
  • IPO Year
  • LIVN 1993
  • KYMR 2020
  • Fundamental
  • Price
  • LIVN $45.70
  • KYMR $44.70
  • Analyst Decision
  • LIVN Strong Buy
  • KYMR Strong Buy
  • Analyst Count
  • LIVN 7
  • KYMR 16
  • Target Price
  • LIVN $59.29
  • KYMR $58.94
  • AVG Volume (30 Days)
  • LIVN 576.2K
  • KYMR 1.3M
  • Earning Date
  • LIVN 07-30-2025
  • KYMR 08-06-2025
  • Dividend Yield
  • LIVN N/A
  • KYMR N/A
  • EPS Growth
  • LIVN N/A
  • KYMR N/A
  • EPS
  • LIVN N/A
  • KYMR N/A
  • Revenue
  • LIVN $1,275,380,000.00
  • KYMR $58,885,000.00
  • Revenue This Year
  • LIVN $8.10
  • KYMR $43.38
  • Revenue Next Year
  • LIVN $5.76
  • KYMR $10.97
  • P/E Ratio
  • LIVN N/A
  • KYMR N/A
  • Revenue Growth
  • LIVN 7.62
  • KYMR N/A
  • 52 Week Low
  • LIVN $32.48
  • KYMR $19.45
  • 52 Week High
  • LIVN $57.35
  • KYMR $53.27
  • Technical
  • Relative Strength Index (RSI)
  • LIVN 51.18
  • KYMR 56.46
  • Support Level
  • LIVN $44.28
  • KYMR $43.51
  • Resistance Level
  • LIVN $46.17
  • KYMR $46.67
  • Average True Range (ATR)
  • LIVN 1.13
  • KYMR 1.87
  • MACD
  • LIVN -0.27
  • KYMR -0.88
  • Stochastic Oscillator
  • LIVN 22.61
  • KYMR 10.06

About LIVN LivaNova PLC

UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: